ANDAORALCAPSULE
Approved
Apr 1971
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CLOXACILLIN SODIUM (cloxacillin sodium) by Bristol Myers Squibb is action: cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication. First approved in 1971.
Drug data last refreshed 1w ago
Mechanism of Action
ACTION: Cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide. It is active against gram-positive organisms associated with mastitis such as Staphylococcus…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on CLOXACILLIN SODIUM at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.